Limited Commercial Launch of SeaSpine WaveForm TLIF Oblique 3D-Printed Interbody
The 3D-printed WaveForm TLIF Oblique system was designed for both posterior and transforaminal lumbar interbody fusion. Apr 20, 2021
BONESUPPORT Awarded Synthetic Implantable Products Agreement with Premier
The group purchasing agreement for Synthetic Implantable Products allows Premier members to access pricing and terms for CERAMENT bone void filler. Apr 20, 2021
Zimmer Biomet ANZ Enters New Agreement with Device Technologies
Zimmer Biomet appointed Device Technologies as an exclusive distributor in Australia and New Zealand for sports medicine, foot/ankle and trauma portfolios. Apr 19, 2021
AgNovos Healthcare Receives Investigational Device Exemption for Breakthrough Spine Device
The IDE for the AGN1 Local Osteo-enhancement Procedure Small Volume kit will support study of the device to treat vertebral compression fractures. Apr 19, 2021
First Cases with Globus Medical CREO ONE Robotic Screw
CREO ONE simplifies pedicle preparation while maintaining navigational accuracy and increasing pullout strength by 86% vs. traditional pedicle screws. Apr 16, 2021
Biogennix Launches Agilon Strip Advanced Bone Grafting Solution
Agilon Strip was designed to maximize direct contact with bone when implanted, with one of the highest granule-to-strip ratios on the market. Apr 16, 2021
Amplify Surgical Announces 1,000th Level Treated with dualX Dual Expanding Interbody Fusion Implant
The company reached the milestone of treating 1,000 spinal levels with the dualX Dual Expanding Interbody Fusion System. Apr 14, 2021
Ventris Launches Next Generation Allocell AF Biologic
Allocell AF is designed with broad, augmented bone fibers that maximize the surface area, allowing the fibers to better fill the defect site. Apr 14, 2021
Hensler Surgical Obtains CE Mark Approval for Hensler Bone Press
The press uses a 2-step technique to harvest autologous material during bony decompressions such as laminectomy, vertebral corpectomy, foot/ankle surgery, etc. Apr 14, 2021
Kuros Biosciences Treats First Patient in Clinical Trial of MagnetOs Putty
Kuros Biosciences treated the first patient in a prospectively designed, randomized controlled U.S. trial named PROOF, comparing MagnetOs Putty to... Apr 14, 2021
